BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

The Immune Response Corporation, Inc. 

5935 Darwin Court

Carlsbad  California  92008  U.S.A.
Phone: 760-431-7080 Fax: 760-431-8636


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
The Immune Response Corporation, Inc. (IMNR) Announces Rebranding to Reflect Expanded Focus on Treatment of Autoimmune Diseases 4/4/2007 1:37:40 PM    More...
The Day In Review: Hollis-Eden Pharmaceuticals Inc. (HEPH) Loses Stockpile Contract For Neumune 3/8/2007 5:45:06 PM    More...
The Immune Response Corporation, Inc. (IMNR) Injects First Patient in Trial of NeuroVax(TM) for Treatment of Multiple Sclerosis 3/8/2007 11:19:47 AM    More...
The Immune Response Corporation, Inc. (IMNR) Extends Warrants Exercise Deadline 3/1/2007 11:07:38 AM    More...
The Immune Response Corporation, Inc. (IMNR)'s Interim Phase II Data Suggest Both REMUNE And IR103 Stabilize CD4+ Cell Counts In Drug-Naive HIV Patients 2/15/2007 10:28:53 AM    More...
The Immune Response Corporation, Inc. (IMNR) Announces Receipt Of Milestone Payment From NovaRx Corporation 1/5/2007 11:50:51 AM    More...
The Immune Response Corporation, Inc. (IMNR) Announces New Trading Symbol As One-For-100 Reverse Stock Split Takes Effect 12/21/2006 2:34:38 PM    More...
The Immune Response Corporation, Inc. (IMNR) To Present At New York Society of Security Analysts 10th Annual Biotech/Specialty Pharma Industry Conference 12/12/2006 2:13:35 PM    More...
The Immune Response Corporation, Inc. (IMNR) Announces That Previously Approved One-for-100 Reverse Stock Split Will Take Effect On December 20, 2006 12/11/2006 11:56:44 AM    More...
The Immune Response Corporation, Inc. (IMNR) To Present At The Wall Street Analyst Forum Biotechnology And Healthcare Conference 12/4/2006 3:11:02 PM    More...
12345678910